Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this FDA Warning Letter issued to Rocky Mountain Pharmacy Inc. on May 9, 2019, concerns drug products and their manufacturing or distribution practices. Without access to the full letter text or detailed subject information, the specific nature of the violations cannot be determined from the available metadata alone. The warning falls under FDA's drug regulatory authority, though the specific issuing office is not identified in the metadata provided. To understand the full scope and details of the compliance issues, review of the complete Warning Letter document would be necessary.